User contributions
Jump to navigation
Jump to search
- 02:49, 24 December 2011 diff hist -124 Arsenic trioxide (Trisenox) delete regimen section
- 02:47, 24 December 2011 diff hist -124 Amsacrine (Amsidine) delete regimens section
- 02:46, 24 December 2011 diff hist +25 Trebananib (AMG-386)
- 02:46, 24 December 2011 diff hist -124 Altretamine (Hexalen) delete regimens section
- 02:45, 24 December 2011 diff hist -124 Alemtuzumab (Campath) delete regimens section
- 02:45, 24 December 2011 diff hist -141 Aldesleukin (Proleukin) delete regimens section
- 02:30, 24 December 2011 diff hist +1 Mechlorethamine (Mustargen) →Patient drug information
- 02:27, 24 December 2011 diff hist +241 Interferon alfa-2a (Roferon-A)
- 01:53, 24 December 2011 diff hist +33 Imatinib (Gleevec)
- 01:49, 24 December 2011 diff hist +283 Idarubicin (Idamycin)
- 01:46, 24 December 2011 diff hist -38 Drug index →H
- 01:45, 24 December 2011 diff hist -1,503 Hexamethylmelamine (Altretamine) Redirected page to Altretamine (Hexalen) current
- 01:42, 24 December 2011 diff hist +35 N Hexamethylmelamine Redirected page to Altretamine (Hexalen) current
- 01:41, 24 December 2011 diff hist +34 Altretamine (Hexalen)
- 01:40, 24 December 2011 diff hist +34 N Ara-C Redirected page to Cytarabine (Cytosar)
- 01:25, 24 December 2011 diff hist +1,077 N Bosutinib (Bosulif) Created page with "==General information== Class/mechanism: Third-generation tyrosine kinase inhibitor, targets Abl and Src kinases. Active against many imatinib-resistant mutations, but is not ac..."
- 00:54, 24 December 2011 diff hist +25 Drug index →B
- 23:24, 23 December 2011 diff hist +11 Ipilimumab (Yervoy)
- 00:51, 21 December 2011 diff hist -26 m Drug index →E
- 16:02, 20 December 2011 diff hist +1 m Drug index →C
- 15:52, 20 December 2011 diff hist -25 Trebananib (AMG-386) →General information
- 15:52, 20 December 2011 diff hist +1,135 N Trebananib (AMG-386) Created page with "==General information== Class/mechanism: Selective angiopoietin 1/2-neutralizing peptibody, interferes with interactions of angiopoietins and Tie2 receptors, inhibiting angiogene..."
- 15:49, 20 December 2011 diff hist +38 Drug index →A
- 15:47, 20 December 2011 diff hist -2 Trastuzumab emtansine (Kadcyla) →General information
- 15:37, 20 December 2011 diff hist -2 Trastuzumab emtansine (Kadcyla) →General information
- 15:36, 20 December 2011 diff hist +1,501 N Trastuzumab emtansine (Kadcyla) Created page with "==General information== Class: Antibody (trastuzumab) with linker to chemotherapeutic agent (emtansine). Humanized monoclonal antibody binds to subdomain IV of HER2, facilitatin..."
- 15:27, 20 December 2011 diff hist +25 Drug index →T
- 15:25, 20 December 2011 diff hist +35 Drug index →T
- 15:24, 20 December 2011 diff hist +81 Pertuzumab (Perjeta)
- 15:23, 20 December 2011 diff hist +1,056 N Pertuzumab (Perjeta) Created page with "==General information== Class: Humanized monoclonal antibody that binds to subdomain II of HER2, preventing dimerization with other HER receptors, tyrosine kinase activity, and d..."
- 15:16, 20 December 2011 diff hist +14 Paclitaxel, nanoparticle albumin-bound (Abraxane)
- 15:15, 20 December 2011 diff hist +52 Drug index →P
- 14:36, 20 December 2011 diff hist -27 Cabozantinib (Cometriq)
- 14:36, 20 December 2011 diff hist +1,009 N Cabozantinib (Cometriq) Created page with "==General information== Class/mechanism: Small molecule that inhibits multiple tyrosine kinases: MET, VEGFR2, RET, and KIT.<ref>[http://www.exelixis.com/cabozantinib Exelixis sit..."
- 14:31, 20 December 2011 diff hist +8 Drug index →C
- 14:29, 20 December 2011 diff hist +42 Drug index →C
- 16:42, 19 December 2011 diff hist +10 Main Page →HemOnc.org - A Free Hematology/Oncology Reference
- 16:23, 19 December 2011 diff hist -18 HemOnc.org - An Oncology Wiki:General disclaimer Redirected page to HemOnc.org - A Hematology Oncology Wiki:General disclaimer current
- 16:22, 19 December 2011 diff hist +90 N HemOnc.org - An Oncology Wiki:General disclaimer Redirected page to Http://hemonc.org/HemOnc.org - A Hematology Oncology Wiki:General disclaimer
- 16:21, 19 December 2011 diff hist +26 m Drug index →C
- 15:52, 11 December 2011 diff hist +1 m Classical Hodgkin lymphoma →References
- 15:42, 11 December 2011 diff hist +2,439 Colon cancer
- 07:41, 11 December 2011 diff hist +4,992 Colon cancer
- 07:32, 11 December 2011 diff hist +33 Drug index
- 06:54, 11 December 2011 diff hist +4,497 N Colon cancer Created page with "==Adjuvant therapy== ===Capecitabine (Xeloda)=== *Capecitabine (Xeloda) 1250 mg/m2 PO BID days 1-14 '''Q21days x 8 cycles''' ====References==== # Twelves C, Wong A, Nowack..."
- 05:53, 11 December 2011 diff hist +31 m Drug index →F
- 05:46, 11 December 2011 diff hist +1,197 List of chemotherapy regimens
- 05:37, 11 December 2011 diff hist 0 Classical Hodgkin lymphoma
- 05:32, 11 December 2011 diff hist -7 Classical Hodgkin lymphoma
- 05:23, 11 December 2011 diff hist +1,191 Classical Hodgkin lymphoma